The International Myeloma Foundation (IMF) Launches Medical Student Scholars for Health Equity in Myeloma Mentoring Program
April 20, 2023 08:45 ET
|
International Myeloma Foundation
STUDIO CITY, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) has partnered with the W. Montague Cobb/NMA Health Institute’s Cobb Scholars Program to develop a...
Parexel Appoints Scott Smith, M.D., Ph.D. as New Head of Hematology
April 19, 2023 09:00 ET
|
Parexel International LLC
DURHAM, N.C., April 19, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Adaptive Biotechnologies Announces Translational Collaboration with Takeda to Measure Minimal Residual Disease with Its clonoSEQ® Assay Across Its Hematologic Malignancy Pipeline
April 12, 2023 07:30 ET
|
Adaptive Biotechnologies
SEATTLE, April 12, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
Veterinary Diagnostics Market Size & Share to Surpass $ 4663.51 Million by 2030 | Vantage Market Research
April 10, 2023 05:00 ET
|
Vantage Market Research
WASHINGTON, April 10, 2023 (GLOBE NEWSWIRE) -- Global Veterinary Diagnostics Market valued at USD 2375.10 Million in 2022 and is projected to reach a value of USD 4663.51 Million by 2030 at a CAGR...
The International Myeloma Foundation Announces the Annual Miles for Myeloma 5K Run/Walk: 15 Years of Making a Difference in the Myeloma Community
April 03, 2023 08:45 ET
|
International Myeloma Foundation
PHILADELPHIA, April 03, 2023 (GLOBE NEWSWIRE) -- The Annual Miles for Myeloma Hybrid 5K Run/Walk will once again “Redefine Being Together” on Saturday, April 29, virtually and in-person at FDR Park...
Aptose Reports Results for the Fourth Quarter and Full Year 2022
March 23, 2023 16:44 ET
|
Aptose Biosciences, Inc.
─ APTIVATE Expansion Trial of Tuspetinib as Single Agent in Relapsed/Refractory AML Patients is Up and Running; Initiated Enrollment of Combination Treatment Arm with Venetoclax ─ ─ RAS Mutated AML...
International Myeloma Foundation (IMF) Launches #MYelomaSTORY Campaign for Myeloma Action Month in March 2023
February 23, 2023 08:45 ET
|
International Myeloma Foundation
STUDIO CITY, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) -- With the International Myeloma Foundation (IMF) at the forefront, Myeloma Action Month is held every year for the whole month of March to...
Home Infusion Therapy Market Revenue to Cross $35.69 Billion, Globally, by 2028 – Exclusive Report by The Insight Partners
February 21, 2023 08:32 ET
|
The Insight Partners
New York, Feb. 21, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Home Infusion Therapy Market Size, Share, Growth, Trends and Global Forecast to 2028 - COVID-19 Impact and Global...
Apheresis Equipment Market Share to Outstrip $3.85 Billion, Globally, by 2028 with 8% CAGR – Growth Report by The Insight Partners
February 09, 2023 09:47 ET
|
The Insight Partners
New York, Feb. 09, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Apheresis Equipment Market Size, Share, Revenue, Sales and Global Forecast to 2028 - Global Analysis by Product...
International Myeloma Foundation (IMF) Returns to In-Person Patient and Family Seminars in 2023, Announces Boca Raton Event
February 02, 2023 08:45 ET
|
International Myeloma Foundation
BOCA RATON, Fla., Feb. 02, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) today announced that this year’s first Patient and Family Seminar is taking place in-person and...